Cipro Hc Suspension/ Drops
Product Images NDC 50090-7631

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cipro Hc (NDC 50090-7631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ciprofloxacin Chemical Structure (Image 01)

Ciprofloxacin Chemical Structure (Image 01)
Chemical structure of ciprofloxacin hydrochloride recognizable by its bicyclic quinolone core with a fluorine atom and a piperazine ring.*
FDA Label Image

Hydrocortisone Chemical Structure (Image 02)

Hydrocortisone Chemical Structure (Image 02)
Chemical structure diagram showing a steroid molecule with multiple hydroxyl and carbonyl functional groups. The structure features a multi-ring system typical of corticosteroids, with defined stereochemistry indicated by solid and dashed wedges.*
FDA Label Image

Label Image (Lbl500907631)

Label Image (Lbl500907631)
Label for CIPRO HC suspension/drops containing ciprofloxacin hydrochloride 0.2% and hydrocortisone 1%. The auricular (otic) product is manufactured by A-S Medication Solutions, with a package size of 10 mL. The label includes dosage instructions, storage conditions, and the product NDC 50090-7631.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.